Drreddys Laboratories reported $26.85B in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Ani Pharmaceuticals ANIP:US $ 34.27M 373K
Aurora Cannabis Inc ACB:CN 103.36M 6.41M
Bayer BAYN:GR € 5176M 1491M
Canopy Growth Corp WEED:CN C$ 271.01M 140.13M
Catalent CTLT:US $ 850M 38M
Cipla CIPLA:IN 21.47B 33.3M
Corcept Therapeutics CORT:US $ 1.25M 0.1M
Endo International Ordinary Shares ENDP:US $ 179.76M 42.71M
GlaxoSmithKline GSK:LN 3645M 30M
Hikma Pharmaceutical HIK:LN 652M 52M
Horizon Pharma HZNP:US $ 215.06M 26.45M
JAZZ PHA JAZZ:US $ 115.28M 20.87M
Lannett LCI:US $ 75.28M 5.52M
Lonza Group LONN:SW 1.8B 301M
Novartis NOVN:VX SF 3755M 245M
Pacira Pharmaceuticals PCRX:US $ 36.07M 2.93M
Phibro Animal Health PAHC:US $ 167.99M 5.95M
Prestige Brands PBH:US $ 118.07M 1.34M
Richter Gedeon RICHT:HB 72.06B 7.1B
Sun Pharmaceuticals SUNP:IN IR 25396.3M 1009.9M
Supernus Pharmaceuticals SUPN:US $ 17.93M 0.94M
Teva Pharmaceutical TEVA:IT 1.86B 116M